Healthcare Realty Trust Inc
For the period ended Sep 30, 2026. Filed Oct 29, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 29, 2026
HR$19.35-0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
For the Nine Months Ended September 30, 2026 and 2025
Amounts in thousands
| NINE MONTHS ENDED SEPTEMBER 30, | ||
|---|---|---|
| OPERATING ACTIVITIES | 2026 | 2025 |
| Net loss | $(59,786) | $(264,076) |
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||
| Depreciation and amortization | 385,152 | 436,558 |
| Other amortization | 34,284 | 35,487 |
| Share-based compensation | 14,405 | 19,035 |
| Amortization of straight-line rent receivable (lessor) | (29,357) | (22,354) |
| Amortization of straight-line rent on operating leases (lessee) | 1,529 | 2,566 |
| Gain on sales of real estate properties and other assets | (16,966) | (99,678) |
| Loss on extinguishment of debt | 1,718 | 286 |
| Loss on derivatives | — | 2,844 |
| Impairment of real estate properties and credit loss recoveries (reserves) | 57,909 | 258,791 |
| Equity income from unconsolidated joint ventures | (4,241) | (446) |
| Distributions of earnings from unconsolidated joint ventures | 15,450 | 16,487 |
| Non-cash interest from financing and notes receivable | (271) | (657) |
| Changes in operating assets and liabilities: | ||
| Other assets, including right-of-use-assets | (41,414) | (26,035) |
| Accounts payable and accrued liabilities | (22,321) | (32,993) |
| Other liabilities | (18,742) | (1,059) |
| Net cash provided by operating activities | 317,349 | 324,756 |
| INVESTING ACTIVITIES | ||
| Acquisitions of real estate | (6,909) | — |
| Development of real estate | — | (12,605) |
| Additional long-lived assets | (194,578) | (243,605) |
| Funding of mortgages and notes receivable | (7,678) | (6,027) |
| Investments in unconsolidated joint ventures | (47,889) | (1,546) |
| Investment in financing receivable | 492 | (497) |
| Proceeds from sales of real estate properties and additional long-lived assets | 73,892 | 393,111 |
| Distributions in excess of earnings from unconsolidated joint ventures | 8,766 | — |
| Proceeds from insurance recoveries | 6,723 | 2,000 |
| Proceeds from notes receivable repayments | 53,441 | 53,513 |
| Net cash (used in) provided by investing activities | (113,740) | 184,344 |
| FINANCING ACTIVITIES | ||
| Borrowings on unsecured credit facility | 295,000 | 831,000 |
| Repayments on unsecured credit facility | (415,000) | (682,000) |
| Net borrowings on commercial paper program | 346,945 | — |
| Repayment on term loans | — | (108,532) |
| Borrowings of notes and bonds payable | 700,000 | — |
| Redemption and repayments of notes and bonds payable | (605,915) | (251,042) |
| Dividends paid | (248,400) | (302,528) |
| Common stock redemptions | (2,815) | (3,628) |
| Common stock repurchases | (225,055) | — |
| Payments made for capped call premiums | (28,948) | — |
| Distributions to non-controlling interest holders | (3,165) | (3,884) |
| Redemption of non-controlling interest | (1,043) | (677) |
| Debt issuance and assumption costs | (23,849) | (13,083) |
| Payments made on finance leases | (37) | (145) |
| Net cash used in financing activities | (212,282) | (534,519) |
| Increase (decrease) in cash and cash equivalents | (8,673) | (25,419) |
| Cash and cash equivalents cash at beginning of period | 26,172 | 68,916 |
| Cash and cash equivalents at end of period, including held for sale | 17,499 | 43,497 |
| Cash and cash equivalents held for sale | — | (152) |
| Cash and cash equivalents at end of period | $17,499 | $43,345 |
| NINE MONTHS ENDED SEPTEMBER 30, | ||
|---|---|---|
| Supplemental Cash Flow Information | 2026 | 2025 |
| Interest paid | $127,410 | $160,215 |
| Mortgage notes receivable taken in connection with sale of real estate | $— | $5,400 |
| Invoices accrued for construction, tenant improvements and other capitalized costs | $46,186 | $42,711 |
| Proceeds from dispositions held in escrow | $— | $56,915 |
| Capitalized interest | $9,671 | $8,591 |
The accompanying notes, together with the Notes to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, are an integral part of these financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.